OEM News

Arcuro Medical Surpasses 4,000 Case Milestone

The SuperBall Meniscal Repair System’s unique tensioning mechanism enables surgeons to have complete control of the fix.

Author Image

By: Michael Barbella

Managing Editor

Arcuro Medical Ltd., has exceeded 4,000 surgical cases worldwide, and 1,000 cases in the United States with its SuperBall Meniscal Repair System.

“We are excited to have reached this important milestone of global cases, and most significantly surpassing 1,000 cases here in the U.S. We look forward to continuing growth with our expanded U.S. sales organization,” Arcuro CEO Jamal Rushdy said.
 
The current version of the SuperBall Meniscal Repair System, commercially launched in 2022, with additional line extensions introduced in late 2023, addresses a full range of meniscus tear patterns. SuperBall is an all-inside, all-suture, knotless meniscal repair device that replaces hard polymer implants with soft flexible suture bundles. The SuperBall’s unique tensioning mechanism enables surgeons to have complete control of the repair, mimicking inside-out tensioning of the meniscus. Its proprietary repair suture mesh lays flat, protecting the repaired meniscus and the articulating cartilage, while the SuperBall extracapsular fixation secures the repair and leaves no knots in the joint space. 
 
“The SuperBall Meniscal Repair System provides an important all-suture, knotless tool for surgeons to effectively address a wide range of tears,” Arcuro Medical Director Philip Davidson, M.D., stated. “Its unique tensioning mechanism is similar to the inside-out gold standard technique and has been shown to provide superior strength and reduced deployment failure and other complications associated with other meniscus repair devices.”1
 
Recently, Arcuro made two key hires in the United States to focus on commercial growth in this market, welcoming orthopedic industry veterans Rushdy as CEO and Nick Tonno as sales director. The company’s focus is to continue to grow its business in the United States and expand its product offering.
 
Arcuro Medical Ltd. is a portfolio company of The Trendlines Group, which is headquartered in Israel but maintains U.S. operations in Minneapolis, Minn., and Naples, Fla. The compan was founded by executives with more than 40 years’ combined experience developing and manufacturing minimally invasive orthopedic products, bringing medical devices from concept to market. Arcuro is expanding its established worldwide distribution network to introduce its SuperBall technology to healthcare professionals in every market. The company continues to develop technologies for sports medicine. 

Reference 
1 Barber et al. Biomechanical Characteristics of All-Suture Meniscal Repair Devices Compared With PEEK-Anchored Devices and Inside-Out Suture for Meniscal Repair: A Porcine Study. Orthop J Sports Med. 2024;12(5)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters